MiR-29a suppresses growth and invasion of gastric cancer cells in vitro by targeting VEGF-A

BMB Reports

Volumn 47, Issue 1, 2014, Pages 39-44

  Chen, Ling ^a   Xiao, Hong ^a   Wang, Zong Hua ^b   Huang, Yi ^a   Liu, Zi Peng ^a   Ren, Hui ^b   Song, Hang ^a  

^a The 324th hospital of PLA   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Gastric cancer; Hsa miR 29a; MicroRNAs; Post transcriptional regulation; VEGF A

Indexed keywords

MESSENGER RNA; MICRORNA; MIRN29 MICRORNA, HUMAN; VASCULOTROPIN A;

ARTICLE; CELL MOTION; CELL PROLIFERATION; DOWN REGULATION; DRUG ANTAGONISM; FEMALE; GENETICS; HEK293 CELL LINE; HUMAN; MALE; METABOLISM; METASTASIS; MICROVASCULATURE; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; SEQUENCE ALIGNMENT; STOMACH TUMOR; TUMOR CELL LINE;

BASE SEQUENCE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; HEK293 CELLS; HUMANS; MALE; MICRORNAS; MICROVESSELS; NEOPLASM METASTASIS; RNA, MESSENGER; SEQUENCE ALIGNMENT; STOMACH NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84893394683     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2014.47.1.079     Document Type: Article

References (38)

1. Kloosterman, W. P. and Plasterk, R. H. (2006) The diverse functions of microRNAs in animal development and disease. Dev. Cell 11, 441-450.
2. Esquela-Kerscher, A. and Slack, F. J. (2006) Oncomirs-microRNAs with a role in cancer. Nat. Rev. Cancer 6, 259-269.
3. Lewis, B. P., Burge, C. B. and Bartel, D. P. (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20.
4. Wicha, M. S. (2011) Stemming a tumor with a little miR. Nat. Med. 17, 162-164.
5. Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M. and Croce, C. M. (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. U. S. A. 101, 2999-3004.
6. Zhu, S., Wu, H., Wu, F., Nie, D., Sheng, S. and Mo, Y. Y. (2008) MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res. 18, 350-359.
7. Hiyoshi, Y., Kamohara, H., Karashima, R., Sato, N., Imamura, Y., Nagai, Y., Yoshida, N., Toyama, E., Hayashi, N., Watanabe, M. and Baba, H. (2009) MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma. Clin. Cancer Res. 15, 1915-1922.
8. Huang, L., Luo, J., Cai, Q., Pan, Q., Zeng, H., Guo, Z., Dong, W., Huang, J. and Lin, T. (2011) MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3. Int. J. Cancer 128, 1758-1769.
9. Lo, W. L., Yu, C. C., Chiou, G. Y., Chen, Y. W., Huang, P. I., Chien, C. S., Tseng, L. M., Chu, P. Y., Lu, K. H., Chang, K. W., Kao, S. Y. and Chiou, S. H. (2011) MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells. J. Pathol. 223, 482-495.
10. Li, N., Fu, H., Tie, Y., Hu, Z., Kong, W., Wu, Y. and Zheng, X. (2009) miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. Cancer Lett. 275, 44-53.
11. Ward, B. P., Tsongalis, G. J. and Kaur, P. (2011) MicroRNAs in chronic lymphocytic leukemia. Exp. Mol. Pathol. 90, 173-178.
12. Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M. and Croce, C. M. (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. U. S. A. 101, 2999-3004.
13. Desjobert, C., Renalier, M. H., Bergalet, J., Dejean, E., Joseph, N., Kruczynski, A., Soulier, J., Espinos, E., Meggetto, F., Cavaille, J., Delsol, G. and Lamant, L. (2011) MiR-29a downregulation in ALK-positive anaplastic large-cell lymphomas contributes to apoptosis blockadethrough MCL-1 overexpression. Blood. 117, 6627-6637.
14. Grimson, A., Farh, K. K., Johnston, W. K., Garrett-Engele, P., Lim, L. P. and Bartel, D. P. (2007) MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell 27, 91-105.
15. Maragkakis, M., Alexiou, P., Papadopoulos, G. L., Reczko, M., Dalamagas, T., Giannopoulos, G., Goumas, G., Koukis, E., Kourtis, K., Simossis, V. A., Sethupathy, P., Vergoulis, T., Koziris, N., Sellis, T., Tsanakas, P. and Hatzigeorgiou, A. G. (2009) Accurate microRNA target prediction correlates with protein repression levels. BMC Bioinformatics 10, 295.
16. Maragkakis, M., Reczko, M., Simossis, V. A., Alexiou, P., Papadopoulos, G. L., Dalamagas, T., Giannopoulos, G., Goumas, G., Koukis, E., Kourtis, K., Vergoulis, T., Koziris, N., Sellis, T., Tsanakas, P. and Hatzigeorgiou, A. G. (2009) DIANA-microT web server: elucidating microRNA functions through target prediction. Nucleic Acids Res. 37, W273-276.
17. Rehmsmeier, M., Steffen, P., Hochsmann, M. and Giegerich, R. (2004) Fast and effective prediction of microRNA/target duplexes. RNA 10, 1507-1517.
18. Hirakawa, S., Kodama, S., Kunstfeld, R., Kajiya, K., Brown, L. F. and Detmar, M. (2005) VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J. Exp. Med. 201, 1089-1099.
19. Nicoloso, M. S., Spizzo, R., Shimizu, M., Rossi, S. and Calin, G. A. (2009) MicroRNAs--the micro steering wheel of tumour metastases. Nat. Rev. Cancer 9, 293-302.
20. Pandey, A. K., Verma, G., Vig, S., Srivastava, S., Srivastava, A. K. and Datta, M. (2011) miR-29a levels are elevated in the db/db mice liver and its overexpression leads to attenuation of insulin action on PEPCK gene expression in HepG2 cells. Mol. Cell. Endocrinol. 332, 125-133.
21. Du B, Ma, L. M., Huang, M. B., Zhou, H., Huang, H. L., Shao, P., Chen, Y. Q. and Qu, L. H. (2010) High glucose down-regulates miR-29a to increase collagen IV production in HK-2 cells. FEBS Lett. 584, 811-816.
22. Kawashita, Y., Jinnin, M., Makino, T., Kajihara, I., Makino, K., Honda, N., Masuguchi, S., Fukushima, S., Inoue, Y. and Ihn, H. (2011) Circulating miR-29a levels in patients with scleroderma spectrum disorder. J. Dermatol. Sci. 61, 67-69.
23. Hebert, S. S., Horre, K., Nicolai, L., Papadopoulou, A. S., Mandemakers, W., Silahtaroglu, A. N., Kauppinen, S., Delacourte, A. and De Strooper B (2008) Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc. Natl. Acad. Sci. U. S.A. 105, 6415-6420.
24. Shioya, M., Obayashi, S., Tabunoki, H., Arima, K., Saito, Y., Ishida, T. and Satoh, J. (2010) Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3. Neuropathol. Appl. Neurobiol. 36, 320-330.
25. Ahluwalia, J. K., Khan, S. Z., Soni, K., Rawat, P., Gupta, A., Hariharan, M., Scaria, V., Lalwani, M., Pillai, B., Mitra, D. and Brahmachari, S. K. (2008) Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication. Retrovirology 5, 117.
26. Bandyopadhyay, S., Friedman, R. C., Marquez, R. T., Keck, K., Kong, B., Icardi, M. S., Brown, K. E., Burge, C. B., Schmidt, W. N., Wang, Y. and McCaffrey, A. P. (2011) Hepatitis C virus infection and hepatic stellate cell activation downregulate miR-29: miR-29 overexpression reduces hepatitis C viral abundance in culture. J. Infect. Dis. 203, 1753-1762.
27. Li, J., Zhang, Y., Kuruba, R., Gao, X., Gandhi, C. R., Xie, W. and Li, S. (2011) Roles of miR-29a in the antifibrotic effect of FXR in hepatic stellate cells. Mol. Pharmacol. 89, 191-200.
28. Mulkeen, A. L., Silva, T., Yoo, P. S., Schmitz, J. C., Uchio, E., Chu, E. and Cha, C. (2006) Short interfering RNA-mediated gene silencing of vascular endothelial growth factor: effects on cellular proliferation in colon cancer cells. Arch. Surg. 141, 367-374.
29. Petit, A. M., Rak, J., Hung, M. C., Rockwell, P., Goldstein, N., Fendly, B. and Kerbel, R. S. (1997) Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors. Am. J. Pathol. 151, 1523-1530.
30. Des Guetz G, Uzzan, B., Nicolas, P., Cucherat, M., Morere, J. F., Benamouzig, R., Breau, J. L. and Perret, G. Y. (2006) Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature. Br. J. Cancer 94, 1823-1832.
31. Kolev, Y., Uetake, H., Iida, S., Ishikawa, T., Kawano, T. and Sugihara, K. (2007) Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma. Ann. Surg. Oncol. 14, 2738-2747.
32. Ugalde, A. P., Ramsay, A. J., de la Rosa, J., Varela, I., Marino, G., Cadinanos, J., Lu, J., Freije, J. M. and Lopez-Otin, C. (2011) Aging and chronic DNA damage response activate a regulatory pathway involving miR-29 and p53. EMBO J. 30, 2219-2232.
33. Cui, Y., Su, W. Y., Xing, J., Wang, Y. C., Wang, P., Chen, X. Y., Shen, Z. Y., Cao, H., Lu, Y. Y. and Fang, J. Y. (2011) MiR-29a inhibits cell proliferation and induces cell cycle arrest through the downregulation of p42.3 in human gastric cancer. PLoS One 6, e25872.
34. Ghosh, R., Lipson, K. L., Sargent, K. E., Mercurio, A. M., Hunt, J. S., Ron, D. and Urano, F. (2010) Transcriptional regulation of VEGF-A by the unfolded protein response pathway. PLoS One 5, e9575.
35. Livak, K. J. and Schmittgen, T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408.
36. Weidner, N., Folkman, J., Pozza, F., Bevilacqua, P., Allred, E. N., Moore, D. H., Meli, S. and Gasparini, G. (1992) Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J. Natl. Cancer Inst. 84, 1875-1887.
37. Tie, J., Pan, Y., Zhao, L., Wu, K., Liu, J., Sun, S., Guo, X., Wang, B., Gang, Y., Zhang, Y., Li, Q., Qiao, T., Zhao, Q., Nie, Y. and Fan, D. (2010) MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet. 6, e1000879.
38. Zhu, S., Si, M. L., Wu, H. and Mo, Y. Y. (2007) MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J. Biol. Chem. 282, 14328-14336.